JP2014139182A5 - - Google Patents

Download PDF

Info

Publication number
JP2014139182A5
JP2014139182A5 JP2014023681A JP2014023681A JP2014139182A5 JP 2014139182 A5 JP2014139182 A5 JP 2014139182A5 JP 2014023681 A JP2014023681 A JP 2014023681A JP 2014023681 A JP2014023681 A JP 2014023681A JP 2014139182 A5 JP2014139182 A5 JP 2014139182A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
hydroxyapatite
treatment
calcification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014023681A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014139182A (ja
JP5908933B2 (ja
Filing date
Publication date
Priority claimed from ES200600377A external-priority patent/ES2280136B1/es
Application filed filed Critical
Publication of JP2014139182A publication Critical patent/JP2014139182A/ja
Publication of JP2014139182A5 publication Critical patent/JP2014139182A5/ja
Application granted granted Critical
Publication of JP5908933B2 publication Critical patent/JP5908933B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014023681A 2006-02-17 2014-02-10 フィチン酸塩と亜鉛の一定量組み合わせ Expired - Fee Related JP5908933B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP-200600377 2006-02-17
ES200600377A ES2280136B1 (es) 2006-02-17 2006-02-17 Asociacion a dosis fija de fitato y zinc.

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008554771A Division JP5554499B2 (ja) 2006-02-17 2007-02-14 フィチン酸塩と亜鉛の一定量組み合わせ

Publications (3)

Publication Number Publication Date
JP2014139182A JP2014139182A (ja) 2014-07-31
JP2014139182A5 true JP2014139182A5 (enExample) 2014-09-18
JP5908933B2 JP5908933B2 (ja) 2016-04-26

Family

ID=38007006

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008554771A Expired - Fee Related JP5554499B2 (ja) 2006-02-17 2007-02-14 フィチン酸塩と亜鉛の一定量組み合わせ
JP2014023681A Expired - Fee Related JP5908933B2 (ja) 2006-02-17 2014-02-10 フィチン酸塩と亜鉛の一定量組み合わせ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008554771A Expired - Fee Related JP5554499B2 (ja) 2006-02-17 2007-02-14 フィチン酸塩と亜鉛の一定量組み合わせ

Country Status (18)

Country Link
US (2) US8377908B2 (enExample)
EP (1) EP1984001B1 (enExample)
JP (2) JP5554499B2 (enExample)
CN (1) CN101384266B (enExample)
AT (1) ATE516035T1 (enExample)
AU (1) AU2007216453B2 (enExample)
BR (1) BRPI0707008A2 (enExample)
CA (1) CA2641216C (enExample)
CY (1) CY1111913T1 (enExample)
DK (1) DK1984001T3 (enExample)
ES (1) ES2280136B1 (enExample)
MX (1) MX2008010502A (enExample)
NO (1) NO341286B1 (enExample)
PL (1) PL1984001T3 (enExample)
PT (1) PT1984001E (enExample)
RU (1) RU2415673C2 (enExample)
SI (1) SI1984001T1 (enExample)
WO (1) WO2007093611A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
AU2011373141B2 (en) * 2011-07-12 2015-12-10 The Procter & Gamble Company Oral care compositions comprising phytic acid
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
BR112017012809B1 (pt) 2014-12-26 2020-09-24 Colgate-Palmolive Company Composição para higiene bucal e uso de um complexo de polifosfato de zinco solúvel na preparação da mesma
DE102016013737A1 (de) 2016-11-17 2018-05-17 WindplusSonne GmbH Hexahydroxycyclohexanhexaphosphorsäureestersalze zur Behandlung von Kalzinose sowie diätische Lebensmittel mit Hexahydroxycyclohexanhexaphosphorsäureestersalzen als Zusatzstoffe
CN108444985B (zh) * 2018-04-25 2021-02-02 山西省食品药品检验所(山西省药品包装材料监测中心) 一种肾精子icp-ms鉴别方法及应用
US20210347793A1 (en) * 2018-09-18 2021-11-11 Inositec Ag Calcium oxalate crystallization inhibitors for renal disorders
US11633416B1 (en) 2020-03-06 2023-04-25 Arcus Biosciences, Inc. Oral formulations of CD73 compounds

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934001A (en) * 1965-12-07 1976-01-20 Lever Brothers Company Oral compositions containing germicidally active plastic powders
NL149701C (nl) 1965-12-08 1981-05-15 Procter & Gamble Werkwijze voor het bereiden van een tegen tandsteen werkzaam tandverzorgingsmiddel, dat als werkzaam bestanddeel een fosfonzuurderivaat bevat, alsmede gevormd tandverzorgingsmiddel.
US3934002A (en) 1972-06-30 1976-01-20 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4215105A (en) 1978-10-27 1980-07-29 Colgate-Palmolive Company Anticalculus oral composition
JPS5846483B2 (ja) * 1979-09-20 1983-10-17 ライオン株式会社 口腔用組成物
JPS5835965B2 (ja) 1979-07-31 1983-08-05 ライオン株式会社 口腔用組成物
JPS6043322B2 (ja) * 1979-09-05 1985-09-27 ライオン株式会社 口腔用組成物
US4515772A (en) * 1982-06-22 1985-05-07 The Procter & Gamble Company Oral compositions
US4808409A (en) 1984-08-16 1989-02-28 Board Of Trustees, University Of Illinois Low cariogenic sweetening agents
JPS6229526A (ja) * 1985-08-01 1987-02-07 Wakamoto Pharmaceut Co Ltd 高カルシウム尿症の治療及び予防剤
US4808401A (en) * 1985-09-13 1989-02-28 Colgate-Palmolive Company Anticalculus oral composition
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
JPH0729909B2 (ja) * 1986-11-28 1995-04-05 ライオン株式会社 口腔用組成物
JPH01305033A (ja) * 1988-06-01 1989-12-08 Sanwa Kagaku Kenkyusho Co Ltd 循環改善剤及び循環改善機能性食品並びにし好品
ES2007238A6 (es) * 1988-06-17 1989-06-01 Univ Illes Balears Procedimiento para la preparacion de fitato-zn (ii)>
US5286479A (en) * 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
US5300289A (en) * 1991-12-10 1994-04-05 The Dow Chemical Company Phytate antimicrobial compositions in oral care products
CN1102978A (zh) * 1993-11-23 1995-05-31 姚焕新 多功能牙膏
JPH08104635A (ja) * 1994-10-06 1996-04-23 Ichimaru Pharcos Co Ltd フィチン酸亜鉛を有効成分とする外用製剤
JPH10182383A (ja) * 1996-12-24 1998-07-07 Lion Corp 口腔用組成物
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
JP2004065249A (ja) * 2002-06-13 2004-03-04 Fumio Hara フィチン酸、イノシトールおよびナイアシンの富化方法、食品の製造方法、並びに食品
ES2232302B1 (es) * 2003-11-07 2006-08-01 Universitat De Les Illes Balears Myo-inositol hexafosfato para uso topico.
CN1259033C (zh) * 2004-06-24 2006-06-14 江西航天日用化工发展有限责任公司 可去除烟黄斑牙垢的复方牙膏及其制备方法
BRPI0619389A2 (pt) * 2005-11-29 2011-10-04 Procter & Gamble composição dentifrìcia compreendendo um sistema aglutinante que compreende material de argila hidrofìlica
CA2634758A1 (en) * 2005-12-20 2007-07-05 The Procter & Gamble Company Oral care compositions comprising zinc and phytate
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.

Similar Documents

Publication Publication Date Title
JP2014139182A5 (enExample)
EP3270938A4 (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
WO2016172658A3 (en) Microbiome regulators and related uses thereof
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2018136264A9 (en) Pyridine compounds as allosteric shp2 inhibitors
EP3212001A4 (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2017136600A8 (en) Compositions and methods for invasive and non-invasive procedural skincare
PL3349783T3 (pl) Kompozycje i sposoby do leczenia chorób
WO2017042607A3 (en) Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
EP3661600A4 (en) FATTY ACID ANALOGS AND ITS USE IN THE TREATMENT OF DISEASES RELATED TO METABOLISM SYNDROME
EA201592003A1 (ru) Микропищевые добавки для иммунитета
EP4424368A3 (en) Compositions comprising an urolithin compound
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
EP3846843A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASES
WO2017029558A3 (en) Methods for improving health of farmed fish
WO2020097568A3 (en) Oligosaccharide compositions and methods of use thereof
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
WO2015075062A3 (en) Method of treating hair
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
EP3145484A4 (en) Dental gel composition of papain for the atraumatic treatment of caries and method of preparing same
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)